Hybridoma Workflow for Antibody Discovery

Hybridoma generation and screening of large antibody libraries

Hybridoma technology is a method for mass-producing antibodies in a hybrid cell line generated from the fusion of antibody-producing B-cells with an immortalized myeloma cell line, now called a hybridoma cell. Because every B-cell produces a unique antibody, single-cell cloning of hybridomas can be used to generate a diverse library of unique monoclonal antibodies at a large scale, which are very frequently used in the prevention, diagnosis, and treatment of disease.

In this video, Justin Dranschak, manager for BioPharma platforms, presents our solution for a hybridoma workflow and references the systems to aid in your research.

https://share.vidyard.com/watch/XT7k1HMuRMAyrUUh5S75A7

Hybridoma workflow

Workflow: Generation and screening of antibody libraries using hybridomas

Step 1: Fusion

The process of fusing B cells, expressing unique antibodies, with myeloma cells creating a hybrid cell line is called a hybridoma.

Step 2: Clone screening

The identification of clonally-derived hybridoma cell lines which are producing high amounts of monoclonal antibodies.

Step 3: Cell growth

Cell growth is determined by monitoring cell divisions over a given period of time using label-free imaging.

Step 4: Specificity and cross reactivity

The process of analyzing the ability of an antibody to bind to only one target antigen.

Step 5: Binding affinity and internalization

Binding affinity is the strength of the binding interaction between a single biomolecule (e.g. protein or DNA) to its ligand/binding partner (e.g. drug or inhibitor). Internalization is the process of monitoring the ability of a given particle to enter into the cell.

Speak to a specialist

COVID-19 research

Accelerate your COVID-19 research

Molecular Devices is committed to supporting scientists that are researching COVID-19 cellular response and vaccine development by offering technology and solutions that you can deploy rapidly.

Go to COVID-19 Research

COVID-19 Applications

Workflow solutions for vaccine development

View a variety of virus-related workflows – from antigent/immunogen and antibody discovery to stable cell line development.

Go to Vaccine Development Workflows

COVID-19 Applications

Applications for critical research

Learn more about how our technology can help your research of COVID-19 and other infectious diseases for vaccine development, therapeutics and diagnostics.

Go to Coronavirus Vaccine Research

Company Message for COVID-19

Company message

As COVID-19 continues to impact the globe, we want to ensure that our partners are fully informed on how Molecular Devices and Danaher are continuing to support you during this difficult period.

Go to COVID-19 Updates

Systems to accelerate your COVID-19 cellular response and vaccine development

We have validated and compliant laboratory solutions including microplate readers, microplate washers, biopharma and cellular imaging systems to meet your research needs.